Emcure Pharmaceuticals (Emcure Pharma) IPO Date, Review, Price, Allotment Details

Emcure Pharmaceuticals IPO Details: Emcure Pharma IPO date is fixed, the IPO is to hit the market on July 3, 2024 and will close on July 5, 2024. Emcure Pharmaceuticals IPO to raise around ₹1952.03 crores via IPO that comprises fresh issue of ₹800 crores and offer for sale up to 11,428,839 equity shares of ₹5 each. The retail quota is 35%, QIB is 50%, and HNI is 15%.
Emcure Pharmaceuticals IPO

Table of Contents


Emcure Pharmaceuticals is an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. They are a research and development (R&D) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled them to reach a range of target markets across over 70 countries, with a strong 218 presence in India, Europe, and Canada.

They were ranked as (i) the 13th largest pharmaceutical company in India in terms of Domestic Sales for MAT Financial Year 2024, (ii) the 4th largest pharmaceutical company by market share in their Covered Markets in terms of Domestic Sales for MAT Financial Year 2024, and (iii) the largest pharmaceutical company in the gynecology and human immunodeficiency virus (HIV) antivirals therapeutic areas in India in terms of Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report). They are led by Promoters with significant experience in the pharmaceutical industry who are supported by a strong professional management team.


Their competitive advantage in the domestic market stems from their differentiated product portfolio, which has allowed us to establish their presence in most of the major therapeutic areas, including gynecology, cardiovascular, vitamins, minerals and nutrients, HIV antivirals, blood-related and oncology/anti-neoplastics. Across the gynecology, vitamins, minerals, and nutrients, HIV antivirals, blood-related, and oncology/antineoplastics therapeutic areas, they were ranked among the 10 largest pharmaceutical companies in India in terms of Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report).

Sales of their iron, chiral, biotherapeutics, injectables, and photo-chemistry products contributed to 52.97% of their revenue from sales in India for the Financial Year 2024, demonstrating their approach towards establishing a differentiated product portfolio. They are focused on pharmaceutical products used in chronic (including sub-chronic) therapeutic areas. Chronic therapeutic areas in the IPM are expected to register higher growth than acute therapeutic areas over the next five Financial Years (Source: CRISIL Report). Chronic therapeutic areas contributed to ₹25,460.48 million or 46.22% of their total Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report).


Objects of the Issue

  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company.
  • General corporate purposes.

Emcure Pharmaceuticals (Emcure Pharma) IPO Review (Apply or Not)

  • Apply

Brokerage Firm IPO Review

  • Swastika Investmart: Apply

Emcure Pharmaceuticals (Emcure Pharma) IPO Date & Price Band Details

IPO Open:July 3, 2024
IPO Close:July 5, 2024
IPO Size:Approx ₹1952.03 Crores, 19,365,346 Equity Share
Fresh Issue:Approx ₹800 Crores, 7,936,507 Equity Share
Offer for Sale:Approx ₹1152.03, 11,428,839 Equity Share
Face Value:₹10 Per Equity Share
IPO Price Band:₹960 to ₹1008 Per Share
IPO Listing on:BSE & NSE
Retail Quota:35%
QIB Quota:50%
 NII Quota:15%
Discount:₹90 Per Share for Employees
DRHP Draft Prospectus:Click Here
RHP Draft Prospectus:Click Here
Anchor Investors List:Click Here

Emcure Pharmaceuticals (Emcure Pharma) IPO Market Lot

The Emcure Pharmaceuticals IPO minimum market lot is 14 shares with ₹14,112 application amount. The retail investors can apply up-to 14 lots with 196 shares or ₹197,568 amount.

ApplicationLot SizeSharesAmount
Retail Minimum114₹14,112
Retail Maximum14196₹197,568
S-HNI Minimum15210₹211,680
B-HNI Minimum71994₹10,01,952

Emcure Pharmaceuticals IPO Allotment & Listing Dates

The Emcure Pharmaceuticals IPO date is July 3 and the close date is July 5. The Emcure Pharmaceuticals IPO allotment will be finalized on July 8 and the IPO listing on July 10.

IPO Open Date:July 3, 2024
IPO Close Date:July 5, 2024
Basis of Allotment:July 8, 2024
Refunds:July 9, 2024
Credit to Demat Account:July 9, 2024
IPO Listing Date:July 10, 2024

You can check IPO subscription status and IPO allotment status on their respective pages.

Emcure Pharmaceuticals IPO Form

How to apply for the Emcure Pharmaceuticals IPO? You can apply for Emcure Pharmaceuticals IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Emcure Pharmaceuticals IPO in the Invest section. The other option is you can apply for Emcure Pharmaceuticals IPO via IPO forms downloaded via NSE and BSE. Check out the Emcure Pharmaceuticals forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.


Emcure Pharmaceuticals Company Financial Report

  ₹ in Crores
YearRevenueExpensePAT
2022₹5918.86₹4946.31₹702.56
2023₹6031.72₹5278.36₹561.85
2024₹6715.24₹5978.08₹527.58

Emcure Pharmaceuticals (Emcure Pharma) IPO Valuation – FY2024

Check Emcure Pharmaceuticals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

Earning Per Share (EPS):₹27.54 per Equity Share
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):16.87%
Net Asset Value (NAV):₹163.22 per Equity Share

Peer Group

  • Dr. Reddy’s Laboratories Limited
  • Cipla Limited
  • Alkem Laboratories Limited
  • Torrent Pharmaceuticals Limited
  • Mankind Pharma Limited
  • Abbott India Limited
  • J. B. Chemicals & Pharmaceutical s Limited

Company Promoters

  • Satish Mehta
  • Sunil Mehta

Emcure Pharmaceuticals (Emcure Pharma) IPO Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/

Emcure Pharmaceuticals (Emcure Pharma) IPO Allotment Status Check

Check Emcure Pharmaceuticals IPO allotment status on Linkintime website allotment URL. Click Here

Emcure Pharmaceuticals IPO Lead Managers aka Merchant Bankers

  • Kotak Mahindra Capital Company Limited 
  • Axis Capital Limited 
  • J.P. Morgan India Private Limited
  • Jefferies India Private Limited 

Company Address

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: [email protected]
Website: https://www.emcure.com/

Emcure Pharmaceuticals (Emcure Pharma) IPO FAQs

What is Emcure Pharmaceuticals IPO?

Emcure Pharmaceuticals IPO is a main-board IPO. They are going to raise ₹1952.03 Crores via IPO. The issue is priced at ₹960 to ₹1008 pr equity share. The IPO is to be listed on BSE & NSE.

When Emcure Pharmaceuticals IPO will open?

The IPO is to open on July 3, 2024 for QIB, NII, and Retail Investors.

What is Emcure Pharmaceuticals IPO Investors Portion?

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

How to Apply the Emcure Pharmaceuticals IPO?

You can apply for Emcure Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

How to Apply the Emcure Pharmaceuticals IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Emcure Pharmaceuticals IPO through Upstox?

Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Emcure Pharmaceuticals IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

What is Emcure Pharmaceuticals IPO Size?

Emcure Pharmaceuticals IPO size is ₹1952.03 crores.

What is Emcure Pharmaceuticals IPO Price Band?

Emcure Pharmaceuticals IPO Price Band is ₹960 to ₹1008.

What is the Emcure Pharmaceuticals IPO Allotment Date?

Emcure Pharmaceuticals IPO allotment date is July 8, 2024.

What is the Emcure Pharmaceuticals IPO Listing Date?

Emcure Pharmaceuticals IPO listing date is July 10, 2024. The IPO is to list on BSE and NSE.

Note: The Emcure Pharmaceuticals IPO price band and date are officially announced. The IPO grey market premium (Emcure Pharmaceuticals IPO Premium) will be added to the IPO grey market page as it will start).

    Share the Post:
    Facebook
    Twitter
    LinkedIn

    Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    OPEN DEMAT ACCOUNT